Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

Summary

The purpose of the study is to evaluate Medpulser electroporation (EPT) with bleomycin with regard to local tumor recurrence, disease-free survival, and overall survival rates versus surgery in recurrent or secondary primary squamous cell carcinoma (SCC) of the anterior oral cavity, soft palate, or tonsil.

Timeline

Start

2004-06

Primary completion

2007-06

Completion

2007-06-01

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment was stopped based on the Data Monitoring Committee's recommendation.”

Drugs

Indications